Rare Diseases: Drugs
The question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the requirement in the NHS England Commercial Framework for New Medicines for medicines to provide value at-or-below NICE’s cost-effectiveness
Answered by Dr Zubir Ahmed
I refer the Hon. Member to the answers my Rt Hon. Friend, the Minister of State for Health gave on 1 September 2025 to Questions 69240, 69241, and 69242.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →